Please wait a minute...
IMAGE/TABLE DETAILS
A comparative analysis of global research and development competition in synthetic biology
WU Xiaoyan, SONG Qi, XU Rui, DING Chenjun, CHEN Fang, GUO Qing, ZHANG Bo
Synthetic Biology Journal    2025, 6 (4): 940-955.   DOI: 10.12211/2096-8280.2024-087
Abstract   (354 HTML50 PDF(pc) (2889KB)(459)  

Synthetic biology is an advanced interdisciplinary field that merges biology, engineering, and technology, emerging as a strategic focus for major economies globally. This study offers a detailed comparative assessment of synthetic biology research and development in the United States, Europe, and China. Through systematic analysis of policy infrastructure, research achievements, technological advancements, and industrial applications, we have identified distinct competitive patterns across these regions. Our findings show that the United States maintains a clear leadership position, particularly in fundamental research, with significant technological capabilities and intellectual property assets. Europe has built an effective regional innovation ecosystem, achieving notable success in research commercialization through integrated collaboration among academic, research, and industrial sectors. While China has made substantial recent investments in synthetic biology, there remain opportunities to enhance high-impact research output, valuable patent development, and technology transfer efficiency compared to Western nations. Notably, China has achieved a leading position in specific areas (cell-free synthetic biology) and major applications (such as CO2-to-starch synthesis and cellulose-to-starch conversion). Based on the above analysis, this paper recommends promoting the high-quality development of China’s synthetic biology industry through five key approaches: improving top-level policy design, strengthening enterprises’ role as primary innovators, achieving breakthroughs in core technologies, optimizing intellectual property strategy, and enhancing the industrial ecosystem. These recommendations aim to promote the sustainable development of China’s synthetic biology sector. This study provides valuable strategic guidance for decision-makers, researchers, and industry stakeholders, aiding them in navigating the global competitive landscape and making informed decisions regarding the development of synthetic biology. {L-End}


分类中国国外
技术创新平台

合成生物研究重大科技基础设施(深圳)

国家合成生物技术创新中心(天津)

上海合成生物学创新中心

美国敏捷生物工厂厂(Agile BioFoundry,ABF)

英国过程创新研究中心心 (The Centre for Process Innovation,CPI)

丹麦诺和诺德基金会生物可持续发展中心(The Novo Nordisk Foundation Center for Biosustainability,DTU Biosustain)

中试放大平台

天津华熙生物平台

江苏华泰疫苗平台

北京千升级中试基地

深圳合成生物产业园

美国生物工业制造和设计生态系统(BioMADE)

欧盟Pilots4U

英国生物试点项目(BioPilots UK)

产业孵化平台

中关村生命科学园孵化器

滨海新区生物制造谷

上海徐汇基地

成都天河园孵化基地

英国合成生物学创新知识中心(SynbiCITE)

荷兰代尔夫特生物技术园区(Biotech Campus Delft)

美国IndieBio

Table 6 Representative platform facilities of the global synthetic biology industry[40]
Other Images/Table from this Article